Creactive protein (CRP) is known to be elevated in those with risk factors common to stroke and dementia, including diabetes,
1,2 obesity,
3 and smoking,
4 and is associated with adverse risk of cardiovascular disease,
5 increased risk of primary stroke,
6 and increased stroke severity.
7 High-sensitivity CRP (hsCRP) is increasingly used in clinical practice as a marker of cardiovascular risk and to guide therapy.
8 Cardiovascular disease
9 and inflammation may also be important in Alzheimer disease,
10 and hsCRP has been suggested to be an Alzheimer disease biomarker.
11 We sought to investigate the cross-sectional association between hsCRP and impairment in specific cognitive domains among a multiethnic nondemented elderly population in northern Manhattan.